The Rapid SARS-CoV-2 Antigen Test Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. It has received FDA Emergency Use Authorization for diagnostic testing.
Manufactured by
Xiamen, Fujian, China
Specializes in developing and manufacturing in vitro diagnostic kits, including point of care and immunoassay products for global markets. Operates a 12,500 square meter facility under ISO 13485:2016 and GMP guidelines, with products approved by China NMPA and exported to over 70 countries. Focuses on diagnostic rapid tests and offers customized solutions alongside comprehensive technical support services.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Access Bio, Inc.
United States · 1 relevant product
Genrui Biotech Inc.
China · 1 relevant product
U-GEN BIOTECHNOLOGY INC.
China · 1 relevant product
Hangzhou AllTest Biotech Co.,Ltd
China · 5 relevant products
Richen Europe S.R.L.
Italy · 2 relevant products
Hangzhou Frenovo Biotech Co., Ltd
China · 3 relevant products
ZİNDE-LAB SAĞLIK HİZ.LTD.ŞTİ.
Türkiye · 2 relevant products
Dialab GmbH
Austria · 1 relevant product
Hangzhou Lysun Biotechnology Co.,Ltd
China · 1 relevant product
Nanjing Leading Medical Technology Co. Ltd.
China · 1 relevant product
71 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 113 closest product alternatives
Access Bio, Inc. · United States
CareStart COVID-19 Rapid Test is a point-of-care diagnostic kit for rapid detection of SARS-CoV-2 infection, with FDA Emergency Use Authorization. The test provides results within 10-15 minutes and is unaffected by Omicron variants. Available in rapid antigen, serology, and molecular formats for clinical and at-home use.
Genrui Biotech Inc. · China
Rapid diagnostic test for qualitative detection of SARS-CoV-2 antigen or serology markers. Available in serological and antigen formats for point-of-care testing applications.
U-GEN BIOTECHNOLOGY INC. · China
SARS-CoV-2 Antigen Rapid Test is an in vitro diagnostic test kit for rapid detection of SARS-CoV-2 antigens. The test provides quick results for COVID-19 screening and diagnosis in clinical and point-of-care settings. Designed for high sensitivity and specificity to support infection control and patient management.
Hangzhou AllTest Biotech Co.,Ltd · China
A rapid diagnostic test that detects SARS-CoV-2 antigen using a swab sample. This test provides point-of-care COVID-19 diagnosis.
Richen Europe S.R.L. · Italy
A rapid diagnostic test for the detection of SARS-COV-2 antigens, designed for quick identification of COVID-19 infection. This product is part of Richen Europe's COVID-19 prevention and diagnosis product line.
Hangzhou Frenovo Biotech Co., Ltd · China
Rapid diagnostic test for detection of SARS-CoV-2 antigen. Provides quick identification of active COVID-19 infection for point-of-care testing.
ZİNDE-LAB SAĞLIK HİZ.LTD.ŞTİ. · Türkiye
A rapid diagnostic test for detecting SARS-CoV-2 antigen in patient samples. This test is used for COVID-19 diagnosis in clinical settings. Available variants: SARS CoV-2 Antigen Rapid Test.
Dialab GmbH · Austria
Rapid antigen test kit for qualitative detection of SARS-CoV-2 in clinical specimens. Designed for point-of-care and laboratory testing with fast turnaround time. Enables quick identification of active COVID-19 infection to support clinical decision-making and infection control.
Hangzhou Lysun Biotechnology Co.,Ltd · China
A rapid visual immunoassay for qualitative detection of SARS-CoV-2 antigens. Designed for self-testing and point-of-care diagnosis of COVID-19 infection.
Nanjing Leading Medical Technology Co. Ltd. · China
Rapid antigen detection test for identifying current SARS-CoV-2 infection. Designed for point-of-care testing applications in clinical and screening settings.
Xiamen Biotime Biotechnology Co., Ltd. · China
Rapid qualitative diagnostic test for detection of SARS-CoV-2 antigen in clinical specimens.
Bioantibody Biotechnology Co., Ltd. · China
Rapid immunoassay test for detection of SARS-CoV-2 infection. Provides quick results for COVID-19 screening and diagnosis.
101 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products